Theme lead: Professor David Rowitch
David Rowitch is a developmental neuroscientist and Head of Department of Paediatrics at the University of Cambridge. Originally from California, he obtained his MD from UCLA and PhD from the University of Cambridge.
David’s laboratory in the Wellcome-MRC Cambridge Stem Cell Institute investigates genetic factors that determine diversity of glia, which comprise 90% of cells in the human brain.
He has applied a developmental neuroscience perspective to better understand white matter injury in premature infants and in multiple sclerosis, and he uses genomic technologies to better diagnose and treat serious neurogenetic disorders in children.
David was appointed to the National Advisory Council for Child Health and Development (USA) in 2020, elected a Fellow of the Academy of Medical Sciences in 2018 and Fellow of the Royal Society in 2021..
Theme co-lead: Dr Sarah Teichmann
Sarah Teichmann is a systems and genome biologist who heads the Cellular Genetics programme at the Wellcome Sanger Institute and is Director of Research at the Cavendish Lab/Dept Physics at the University of Cambridge. Born in Germany to an American mother and German father, she studied biochemistry at Cambridge before completing her PhD at the MRC Laboratory of Molecular Biology.
Sarah’s lab at the Sanger develops and applies cell atlas technologies to decipher human tissue architecture. She is particularly interested in how cellular diversity is generated in the immune system and through development. She has charted the first at-scale maps of various organs and organ systems, and applied her single cell toolkit to diseases from COVID-19 to cancer.
Sarah is co-founder and co-leader of the international Human Cell Atlas consortium together with Aviv Regev (initially at the Broad Institute, now Genentech). This project aims to create reference maps for cells across all human tissues, and has grown to include over two thousand members across the world.
Sarah’s work has been recognised by numerous awards, including the EMBO Gold Medal, Genetics Society Mary Lyons Award and Biochemical Society GlaxoSmithKline Award among others. She is an EMBO Member, ISCB Fellow, and Fellow of the Academy of Medical Sciences and Royal Society.